To determine if venoarterial extracorporeal membrane oxygenation (VA ECMO) as a bridge to left ventricular assist device (LVAD) in heart transplant (HT) candidates (ie, double bridge to HT) was associated with increased morbidity and mortality when compared to LVAD bridging to HT (ie, single bridge to HT).info:eu-repo/semantics/publishe
The new allocation criteria classify patients on veno-arterial extracorporeal membranous oxygenation...
PubMed ID: 22841254Objective: Ventricular assist devices (VAD) are an important therapy that saves t...
BackgroundThe purpose of this study was to compare posttransplantation morbidity and mortality in or...
Advanced heart failure (HF) represents a public health priority due to the increase of affected pati...
Despite advances in medical therapy and mechanical circulatory support (MCS), heart transplant (HT) ...
Background—The use of extracorporeal life support (extracorporeal membrane oxygenation [ECMO]) as a ...
International audienceBackground Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is incre...
Background. Extracorporeal membrane oxygenation (ECMO) is a temporary mechanical circulatory assista...
International audienceBACKGROUND: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as dir...
Ventricular-assist devices (VADs) have benefitted patients with end-stage heart failure as a bridge ...
Introduction Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) is one of the mo...
Background: The number of waitlisted patients requiring mechanical circulatory support (MCS) as a br...
The aim of this study was to evaluate the effect of double bridges with extracorporeal membrane oxyg...
Background: The extracorporeal ventricular assist device (e-VAD) system is designed for left ventric...
Ventricular assist devices (VAD) have benefitted patients with end-stage heart failure as a bridge t...
The new allocation criteria classify patients on veno-arterial extracorporeal membranous oxygenation...
PubMed ID: 22841254Objective: Ventricular assist devices (VAD) are an important therapy that saves t...
BackgroundThe purpose of this study was to compare posttransplantation morbidity and mortality in or...
Advanced heart failure (HF) represents a public health priority due to the increase of affected pati...
Despite advances in medical therapy and mechanical circulatory support (MCS), heart transplant (HT) ...
Background—The use of extracorporeal life support (extracorporeal membrane oxygenation [ECMO]) as a ...
International audienceBackground Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is incre...
Background. Extracorporeal membrane oxygenation (ECMO) is a temporary mechanical circulatory assista...
International audienceBACKGROUND: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as dir...
Ventricular-assist devices (VADs) have benefitted patients with end-stage heart failure as a bridge ...
Introduction Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) is one of the mo...
Background: The number of waitlisted patients requiring mechanical circulatory support (MCS) as a br...
The aim of this study was to evaluate the effect of double bridges with extracorporeal membrane oxyg...
Background: The extracorporeal ventricular assist device (e-VAD) system is designed for left ventric...
Ventricular assist devices (VAD) have benefitted patients with end-stage heart failure as a bridge t...
The new allocation criteria classify patients on veno-arterial extracorporeal membranous oxygenation...
PubMed ID: 22841254Objective: Ventricular assist devices (VAD) are an important therapy that saves t...
BackgroundThe purpose of this study was to compare posttransplantation morbidity and mortality in or...